Lentiviral doxycycline-inducible shRNA constructs for Axin2 (GE Dharmacon, 12006), Tfam (GE Dharmacon, 21780) and RelA (Sigma, TRCN00023583) were purchased for lentivirus preparation. Lentiviral supernatants were collected for 4 days and concentrated using lenti-X concentrator (Clonetech, Cat# 631231). An aliquot of concentrated lentivirus was then used to transduce P0 Nrl–GFP MEFs. For Ascl1 knockdown experiments, control (scramble) shRNA and lentiviral shRNA (a gift from J. Johnson, UT-Southwestern Medical Center; cloned into PLKO.1 (Addgene)) constructs were transduced in MEFs. All lentiviral-transduced cells were selected for 3d in the presence of puromycin (1 μg ml−1). Drug-selected cells were then used for chemical conversion and shRNA induction (Tfam and Axin2) was performed between day 4 and day 8 with doxycycline. Finally, CiPCs were quantified on day 11.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.